John J. Lucas, Ph.D., Appointed Vice President of Academic Affairs at The Wistar Institute

John J. Lucas, Ph.D., Appointed Vice President of Academic Affairs at The Wistar Institute

October 18, 2007

(Philadelphia - October 19, 2007) - John J. Lucas, Ph.D., has been appointed to the new position of vice president of academic affairs at The Wistar Institute, effective November 5. Dr. Lucas currently is associate vice president for research and professor of biochemistry and molecular biology at State University of New York Upstate Medical University.

Dr. Lucas served formerly as director of research and as vice provost for research for SUNY Upstate Medical University. He received his doctorate in biochemistry from the University of California at Davis. He served as a postdoctoral research fellow at Johns Hopkins University School of Medicine. Dr. Lucas has worked in the field of glycobiology for over thirty years and most recently has collaborated on studies of the role of parasite cell surface glycoconjugates and cysteine proteases in trichomonas infections.

In his role as vice president of academic affairs at The Wistar Institute, Dr. Lucas will work with senior scientists and administrators to advance faculty affairs and research initiatives at the Institute. His duties will include identifying new opportunities for research funding and collaboration; implementing institutional research plans; and recruiting and promoting. He will also work with Associate Vice President for Academic Affairs Ellen Puré, Ph.D., in the mentoring program. Dr. Lucas will also work on external scientific affairs, including interactions with neighboring academic institutions and state government funding programs.

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. Discoveries at Wistar led to the creation of the rubella vaccine that eradicated the disease in the United States, human rabies vaccines used worldwide, and a new rotavirus vaccine approved in 2006. Today, Wistar is home to preeminent research programs studying skin cancer, lung cancer, and brain tumors. Wistar Institute Vaccine Center scientists are creating new vaccines against pandemic influenza, HIV, and other diseases threatening global health. The Institute works actively to transfer its inventions to the commercial sector to ensure that research advances move from the laboratory to the clinic as quickly as possible. The Wistar Institute: Today’s Discoveries – Tomorrow’s Cures. On the web at